NCT Number: NCT00450996
Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty
PURPOSE: To assess the impact of duration of topical steroid treatment on the incidence of endothelial graft rejection following normal-risk penetrating keratoplasty (PK). DESIGN: Prospective, institutional, longitudinal, randomized interventional trial including 406 eyes (age: 52 >= 19 years; follow-up: 42 >= 18months). METHODS: Postoperative treatment started with prednisolone acetate 1% eye drops five times daily and was tapered over the first 6 months. Patients were then randomised into either short-term (stop topical steroid treatment) or long-term treatment (continue steroids once daily until 12 months).
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
PURPOSE: To assess the impact of duration of topical steroid treatment on the incidence of endothelial graft rejection following normal-risk penetrating keratoplasty (PK). DESIGN: Prospective, institutional, longitudinal, randomized interventional trial including 406 eyes (age: 52 >= 19 years; follow-up: 42 >= 18 months). METHODS: Postoperative treatment started with prednisolone acetate 1% eye drops five times daily and was tapered over the first 6 months. Patients were then randomised into either short-term (stop topical steroid treatment) or long-term treatment (continue steroids once daily until 12 months). <=
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Low risk keratoplasty
Exclusion criteria
- High risk keratoplasty
Treatment and study plan
Primary outcomes
-
Graft survival
Sponsors and collaborators
Lead sponsor
University of Erlangen-Nürnberg Medical School
Other
Registry information
Official study title
Phase 3: Analysis of a Beneficial Effect of Prolonges Topical Steroid Treatment After Low-risk Penetrating Keratoplasty
Important dates
- Study start
- 1999
- Study completion
- 2007
- First posted
- Mar 22, 2007
- Registry last updated
- Jun 4, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.
NCT04851145
Graft Rejection, Humoral Immunity
Bordeaux, France
View Trial DetailsImmunologic Risk of Pregnancy in Women With Lung Transplantion : a National Multicentric Study
NCT05689905
Graft Rejection, Lung Transplantation
Nantes, Loire Atlantique, France
View Trial DetailsHLA-Identical Sibling Renal Transplant Tolerance
NCT00619528
Graft Rejection, Immunosuppression
Chicago, Illinois, United States
View Trial DetailsMolecular HistoMx Assessment for Kidney Transplant Rejection and Management
NCT07347353
Graft Rejection
Paris, France
View Trial Details